Cargando…

Single-Point Mutations in the N Gene of SARS-CoV-2 Adversely Impact Detection by a Commercial Dual Target Diagnostic Assay

Accurate and rapid diagnostic tests are a critical component for the early diagnosis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and of the overall control strategy for the current pandemic. Nucleic acid amplification tests are the gold standard for diagnosis of acute SARS-CoV-2...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miller, Sharon, Lee, Terence, Merritt, Adam, Pryce, Todd, Levy, Avram, Speers, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8597629/ https://www.ncbi.nlm.nih.gov/pubmed/34787486 http://dx.doi.org/10.1128/Spectrum.01494-21

Ejemplares similares

Deployable Laboratory Response to Influenza Pandemic; PCR Assay Field Trials and Comparison with Reference Methods
por: Inglis, Timothy J. J., et al.
Publicado: (2011)

Diminished amplification of SARS-CoV-2 ORF1ab in a commercial dual-target qRT-PCR diagnostic assay
por: Popping, Stephanie, et al.
Publicado: (2022)

Whole genome sequencing of SARS-CoV-2 from wastewater links to individual cases in catchments
por: Levy, Avram, et al.
Publicado: (2022)

Limitations of a Commercial Assay as Diagnostic Test of Autoimmune Encephalitis
por: Ruiz-García, Raquel, et al.
Publicado: (2021)

A Recurrent Mutation at Position 26340 of SARS-CoV-2 Is Associated with Failure of the E Gene Quantitative Reverse Transcription-PCR Utilized in a Commercial Dual-Target Diagnostic Assay
por: Artesi, Maria, et al.
Publicado: (2020)

An Assay System for Point-of-Care Diagnosis of Tuberculosis using Commercially Manufactured PCB Technology
por: Evans, Daniel, et al.
Publicado: (2017)

Rapid Serological Tests for SARS-CoV-2: Diagnostic Performance of 4 Commercial Assays
por: de Almeida, Sérgio M., et al.
Publicado: (2021)

Evaluation of a Commercial Point-of-Care RT-LAMP Assay for Rapid Detection of SARS-CoV-2
por: Law, Janet Hei Yin, et al.
Publicado: (2023)

Misidentification of the SARS-CoV-2 Mu variant using commercial mutation screening assays
por: Alejo-Cancho, Izaskun, et al.
Publicado: (2022)

Clinical Diagnostic Point-of-Care Molecular Assays for SARS-CoV-2
por: Tolan, Nicole V., et al.
Publicado: (2022)

Determining procalcitonin at point-of-care; A method comparison study of four commercial PCT assays
por: Li, Chunbao, et al.
Publicado: (2021)

Influenza and respiratory syncytial virus are the major respiratory viruses detected from prospective testing of pediatric and adult coronial autopsies
por: Speers, David J., et al.
Publicado: (2013)

Impact of G29179T mutation on two commercial PCR assays for SARS-CoV-2 detection
por: Kami, Wakaki, et al.
Publicado: (2023)

Evaluation of multiple commercial molecular and conventional diagnostic assays for the detection of respiratory viruses in children
por: Gharabaghi, F., et al.
Publicado: (2011)

Point-of-care COVID-19 diagnostics powered by lateral flow assay
por: Zhou, Yaofeng, et al.
Publicado: (2021)

Development of diagnostic and point of care assays for a gammaherpesvirus infecting koalas
por: Wright, Belinda R., et al.
Publicado: (2023)

Comparison of commercial assays and laboratory developed tests for detection of SARS-CoV-2
por: Dust, Kerry, et al.
Publicado: (2020)

Commercial Dengue Rapid Diagnostic Tests for Point-of-Care Application: Recent Evaluations and Future Needs?
por: Blacksell, Stuart D.
Publicado: (2012)

A random mutation capture assay to detect genomic point mutations in mouse tissue
por: Wright, Jocelyn H., et al.
Publicado: (2011)

Diagnostic Performance of Commercially Available Enzyme-Linked Immunosorbent Assay Kit in the Diagnosis of Extrapulmonary Tuberculosis
por: Sankar, Manimuthu Mani, et al.
Publicado: (2013)

COVID-19: a meta-analysis of diagnostic test accuracy of commercial assays registered in Brazil
por: Castro, Rodolfo, et al.
Publicado: (2020)

Diagnostic and analytical performance evaluation of ten commercial assays for detecting SARS-CoV-2 humoral immune response
por: Mylemans, Marnix, et al.
Publicado: (2021)

Evaluation of a PlexZyme-Based PCR Assay and Assessment of COVID-19 Surge Testing Throughput Compared to Cobas SARS-CoV-2
por: Pryce, Todd M., et al.
Publicado: (2021)

From the bench to the hand: Point of need/point of care technologies and analytical assays for field testing and medical diagnostics
por: Giokas, Dimosthenis L., et al.
Publicado: (2022)

Evaluation of Diagnostic Accuracy of Eight Commercial Assays for the Detection of Rubella Virus-Specific IgM Antibodies
por: Hiebert, Joanne, et al.
Publicado: (2022)

Evaluation of eight commercial Zika virus IgM and IgG serology assays for diagnostics and research
por: Low, Swee Ling, et al.
Publicado: (2021)

Evaluation of Diagnostic Accuracy of Eight Commercial Assays for the Detection of Measles Virus-Specific IgM Antibodies
por: Hiebert, Joanne, et al.
Publicado: (2021)

Interpret with caution: An evaluation of the commercial AusDiagnostics versus in-house developed assays for the detection of SARS-CoV-2 virus
por: Rahman, H., et al.
Publicado: (2020)

Direct comparison of Altona-SARS-CoV-2 dual target RT-qPCR Assay with commercial LAMP Assay using throat washes in health care staff testing
por: Wanney, Johannes, et al.
Publicado: (2022)

Comparison of seven commercial RT-PCR diagnostic kits for COVID-19
por: van Kasteren, Puck B., et al.
Publicado: (2020)

Phytochemical Assays of Commercial Botanical Dietary Supplements
por: Krochmal, Robert, et al.
Publicado: (2004)

West Nile Virus Detection and Commercial Assays
por: Tilley, Peter A.G., et al.
Publicado: (2005)

The Performances of Three Commercially Available Assays for the Detection of SARS-CoV-2 Antibodies at Different Time Points Following SARS-CoV-2 Infection
por: Syre, Heidi, et al.
Publicado: (2022)

Assessment of commercial SARS-CoV-2 antibody assays, Jamaica
por: Butterfield, Tiffany R., et al.
Publicado: (2021)

Mutations in Animal SARS-CoV-2 Induce Mismatches with the Diagnostic PCR Assays
por: Elaswad, Ahmed, et al.
Publicado: (2021)

Evaluation of Six Commercial Mid- to High-Volume Antibody and Six Point-of-Care Lateral Flow Assays for Detection of SARS-CoV-2 Antibodies
por: Charlton, Carmen L., et al.
Publicado: (2020)

Comparative assessment of commercial enzyme-linked immunosorbent assay & rapid diagnostic tests used for dengue diagnosis in India
por: Kulkarni, Ruta, et al.
Publicado: (2020)

Diagnostic performance of point-of-care and central laboratory cardiac troponin assays in an emergency department
por: Wilke, Petra, et al.
Publicado: (2017)

An Automated, Quantitative, and Multiplexed Assay Suitable for Point-of-Care Hepatitis B Virus Diagnostics
por: Gani, Adi Wijaya, et al.
Publicado: (2019)

Accuracy of a Dual Path Platform (DPP) Assay for the Rapid Point-of-Care Diagnosis of Human Leptospirosis
por: Nabity, Scott A., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_cedj75nm1fhp6a6llu5h4t8f4u